Position in PRFX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$111,922
New position
Shares Held
81,103
first reported quarter
Ownership
2.67%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#1
of 8 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Yorkville Advisors Global, LP holds $1,228,032 across 3 Drug Manufacturers - Specialty & Generic names. PRFX ranks #2 (9.1% of the industry book) .
All Filings in PRFX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $111,922 | 81,103 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||